Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cheng Cai Tang
Observed names:
C Tang,
CHENG CAI TANG,
Cheng Tang,
Tang, Cheng Cai
Institution:
Beijing University of Chinese Medicine
Observed institutions:
National University of Singapore,
PAREXEL International (United Kingdom),
Beijing University of Chinese Medicine
ORCID:
0000-0003-3052-393X
Observed ORCID:
0000-0003-3052-393X
OpenAlex ID:
A5103154520
Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI Patients
2017
·
Hanna Kim
, Kristina M. Brooks
, et al.
·
Clinical Pharmacology & Therapeutics
·
145
Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates
2018
·
Sheng-Hsuan Tseng
, Chuan Poh Lim
, et al.
·
Antimicrobial Agents and Chemotherapy
·
53
PDF
Pharmacokinetics, safety, and tolerability of single‐ and multiple‐dose exenatide once weekly in C hinese patients with type 2 diabetes mellitus (对中国2型糖尿病患者单次和多次给予艾塞那肽周制剂的药代动力学、安全性和耐受性研究)
2013
·
Yi Min Cui
, Xiao Hui Guo
, et al.
·
Journal of Diabetes
·
19
A model‐based simulation of glycaemic control and body weight when switching from semaglutide to 3.0‐ and 4.5‐mg doses of once‐weekly dulaglutide
2021
·
Lai San Tham
, Kevin M. Pantalone
, et al.
·
Diabetes Obesity and Metabolism
·
16
Model-based simulation of glycaemic effect and body weight loss when switching from semaglutide or dulaglutide to once weekly tirzepatide
2024
·
Shweta Urva
, Joshua A. Levine
, et al.
·
Current Medical Research and Opinion
·
12
333-OR: Oxyntomodulin Analog LY3305677 (LY) Improves Glycemic Control and Weight Loss in Healthy Volunteers and Subjects with Type 2 Diabetes (T2D)
2022
·
CHARLES BENSON
, LAI-SAN THAM
, et al.
·
Diabetes
·
10
18. Glucagon Receptor Antibody LY2786890 Reduced Glucose Levels in Type 2 Diabetes Mellitus Patients (106-LB)
2015
·
Ronan P. Kelly
, Parag Garhyan
, et al.
·
Nederlands Tijdschrift voor Diabetologie
·
9
The effects of Gegen Qinlian decoction and its main constituents on glucolipid metabolic disorders in diabetes: an overview of systematic reviews and meta-analysis
2025
·
Chongxiang Xue
, Ying Chen
, et al.
·
Systematic Reviews
·
5
Practical Applications of a Nausea and Vomiting Model in the Clinical Development of Additional Doses of Dulaglutide
2023
·
Cheng Cai Tang
, Jean Lim
, et al.
·
The Journal of Clinical Pharmacology
·
4
PDF
106-OR: A First-in-Human Single Ascending Dose Study of Oxyntomodulin Analog LY3305677 in Healthy Subjects
2021
·
LAI-SAN THAM
, MELISSA K. THOMAS
, et al.
·
Diabetes
·
3
642-P: A Model-Based Evaluation of Nausea and Vomiting Events for Additional Doses of Dulaglutide in Existing and Dulaglutide-Naïve Patients with Type 2 Diabetes
2021
·
LAI-SAN THAM
, JEAN S.K. LIM
, et al.
·
Diabetes
·
2
643-P: A Model-Based Evaluation of Glycemic and Weight Changes When Switching from Semaglutide to Additional Doses of Dulaglutide
2021
·
LAI-SAN THAM
, KEVIN M. PANTALONE
, et al.
·
Diabetes
943-P: Role of Model-Informed Drug Development in Confirming Additional Clinical Benefits of Dulaglutide
2020
·
LAI-SAN THAM
, JEANNE GEISER
, et al.
·
Diabetes
Abstract: P253 EFFECTS OF SOPHORCARPIDINE ON NUMBER AND FUNCTION OF ENDOTHELIAL PROGENITOR CELLS FROM BONE MARROW OF SD RAT
2009
·
G Wang
, L Xiao
, et al.
·
Atherosclerosis Supplements
Show more works
View as search
Works count:
15
Citation count:
278
H-index:
7
I10-index:
6
Year
Topic
Type